CIRRUS (02507) announced its interim results, with a net profit of $88.123 million, an increase of 35.6% year-on-year.
Xiru (02507) announced its mid-term results for 2026, with revenue of $737 million, an increase of 24.0% year-on-year. Gross profit was $267 million, up 24.2% year-on-year. Profit reached $88.123 million, a year-on-year increase of 35.6%. Earnings per share were $0.24.
CIRRUS (02507) announced its interim results for 2026, reporting revenue of $737 million, an increase of 24.0% year-on-year. Gross profit was $267 million, up 24.2% year-on-year. Profit was $88.123 million, a year-on-year increase of 35.6%. Earnings per share were $0.24.
The announcement stated that the profit growth was mainly due to an increase in aircraft deliveries and growth in CIRRUS services and other areas.
Related Articles
US Stock Market Move | Kanzhun Ltd. Sponsored ADR (BZ.US) surged over 18% with Q2 revenue increasing by 14.1% year-on-year.
US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.
MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.
US Stock Market Move | Kanzhun Ltd. Sponsored ADR (BZ.US) surged over 18% with Q2 revenue increasing by 14.1% year-on-year.
US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.
MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.
RECOMMEND
